Pharmacyclics, Inc. (NASDAQ:PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
Growing the love for investing
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
one anomolous quarter is pumping up their earnings and stock price. None of their drugs have even started stage 3 trials yet. Stock spammers love them.